Cardiometabolic risk factor prevalence in a representative population of adults in India

Affiliations

Comment

Sarah Wild. Lancet Diabetes Endocrinol. 2023 Jul.

. 2023 Jul;11(7):444-446.

doi: 10.1016/S2213-8587(23)00163-8. Epub 2023 Jun 7.

¹ Usher Institute, University of Edinburgh, Edinburgh EH8 9AG, UK. Electronic address: sarah.wild@ed.ac.uk.

No abstract available

Conflict of interest statement

I declare no competing interests.

Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17).
Anjana RM, Unnikrishnan R, Deepa M, Pradeepa R, Tandon N, Das AK, Joshi S, Bajaj S, Jabbar PK, Das HK, Kumar A, Dhandhania VK, Bhansali A, Rao PV, Desai A, Kalra S, Gupta A, Lakshmy R, Madhu SV, Elangovan N, Chowdhury S, Venkatesan U, Subashini R, Kaur T, Dhaliwal RS, Mohan V; ICMR-INDIAB Collaborative Study Group. Anjana RM, et al. Lancet Diabetes Endocrinol. 2023 Jul;11(7):474-489. doi: 10.1016/S2213-8587(23)00119-5. Epub 2023 Jun 7. Lancet Diabetes Endocrinol. 2023. PMID: 37301218